Zugriffe | |
---|---|
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study | 95 |
April 2024 | Mai 2024 | Juni 2024 | Juli 2024 | August 2024 | September 2024 | Oktober 2024 | |
---|---|---|---|---|---|---|---|
Ustekinumab for the treatment of moderate‐to‐severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open‐label CADMUS Jr study | 1 | 2 | 2 | 2 | 11 | 6 | 1 |
Zugriffe | |
---|---|
2020_Philipp_etal.pdf | 131 |